Navigation Links
Novocure™ to Present NovoTTF™ Therapy Data at the 2012 Annual Scientific Meeting of the American Society of Clinical Oncology
Date:5/29/2012

f Research and Development, Novocure Inc.
Dr. Angela Davies, Chief Medical Officer, Novocure Inc.
Date/Time:  Sunday, June 3, 11:30 am – 12:30 pm
Location: ASCO Oncology Professional Hall

Novocure will unveil its ongoing pivotal phase III study, EF14, in newly diagnosed glioblastoma, discussing trial design and rationale at a poster session.  The EF14 study is aimed at establishing NovoTTF therapy in the front line setting with current standard of care and is a follow-up to the successful phase III study, EF11, of NovoTTF monotherapy in recurrent glioblastoma.

  • Ongoing trials: Phase 3 Trial of Tumor Treating Fields (TTFields) together with temozolomide compared to temozolomide (TMZ) alone in Patients with Newly Diagnosed Glioblastoma Multiforme

Presenter:  Dr. Santosh Kesari, University of California, San Diego
Date/Time:  Saturday, June 2, 1:15 pm – 5:15 pm
Session:  Poster, S Hall A2
Abstract #TPS2106

Several clinical trial and experimental data updates will also be published in conjunction with ASCO 2012 and can be found online at http://abstract.asco.org/:

Principal Author:  Dr. Miklos Pless, Kantonsspital, Winterthur, Switzerland
Publication number:  e18012

Principal Author:  Sz
'/>"/>

SOURCE Novocure
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... SEOUL , South Korea, July 2, 2015 ... of a new E-CUBE Series ultrasound system. Developed to ... of clinical areas, the E-CUBE 15 EX produces superb ... outstanding clinical performance in women,s health, general imaging, and ... The latest in the renowned E-CUBE Series, ...
(Date:7/2/2015)... 2015 BGI announced today that its high-throughput ... has been accredited by the American College of ... clinical next-generation-sequencing laboratory to receive the CAP certification in ... in clinical laboratory practices. Complementary to the exiting US FDA ... multiple ISO certifications, the CAP certification enables BGI to ...
(Date:7/2/2015)... , July 2, 2015 Agreement ... improving access to HIV treatments   ... manufacturing agreement to enable production in China ... of the dolutegravir active pharmaceutical ingredient (API), and will allow ... product (dolutegravir 50mg, marketed under the name Tivicay®) for ...
Breaking Medicine Technology:E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3BGI Receives Accreditation from the College of American Pathologists (CAP) 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6
... Heygood, Orr & Pearson are announcing a Los Angeles Superior ... (NYSE: WPI ) and its subsidiary companies to ... lawsuit over the death of a 37-year-old woman who died while ... represents the parents of Nicole Bristol, who died on Feb. ...
... DIEGO, March 21, 2011 Marshall Edwards, Inc.(Nasdaq: ... clinical development of novel therapeutics targeting cancer metabolism, announced ... clinical trial of intravenous Phenoxodiol in combination with cisplatin ... now available on the International Journal of Gynecological ...
Cached Medicine Technology:Heygood, Orr & Pearson: Los Angeles Court Orders Watson Pharmaceuticals to Produce Documents, Provide Depositions in Fentanyl Patch Death Lawsuit 2Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol 2Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol 3
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... The ZAC ... the 2015 swim season with important lessons on how to stay water safe with ... Who Couldn’t, Wouldn’t Swim, authored by The ZAC Foundation co-founders, follows Zeke’s water safety ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... announced today that it has reached an agreement to acquire eRubbermaid.com, an ... largest distributor of Rubbermaid Commercial Products on the web today. ...
(Date:7/2/2015)... PA (PRWEB) , ... July 02, 2015 , ... ... Vaccine Research (CVR) recently received nearly $4 million through five federal grants ... develop vaccines and therapies against the deadly diseases. , The research will ...
(Date:7/2/2015)... ... 02, 2015 , ... B. E. Smith, the only full-service ... a national chief operating officer recruitment for Nicklaus Children’s Hospital in ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Nutraceutical company, is announcing with their launch an intention to partner with companies ... health solutions on the planet. Their innovative water soluble, Cannabidiol (CBD) formulations, combined ...
Breaking Medicine News(10 mins):Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:CleanItSupply.com Acquires eRubbermaid.com 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3
... -- A NewYork-Presbyterian Hospital/Weill Cornell Medical Center review of almost ... therapy reported in a widely publicized study was lost in ... The researchers report in the May ... Medical Association, that medical therapy given to patients who ...
... (HealthDay News) -- Shortages of anesthetics are rampant across the ... The findings revealed that more than 90 percent of ... States) are experiencing a shortage of at least one drug. ... encountered a similar problem, the poll by the American Society ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... -- best known as Tylenol -- regularly for some ... for developing certain blood cancers, University of Washington researchers ... the association between over-the-counter painkillers or nonsteroidal anti-inflammatory drugs ...
... HealthDay Reporter , TUESDAY, May 10 (HealthDay News) -- ... scan the inside of the colon may one day be ... from Japan,s Osaka Medical College have developed a "self-propelled capsule ... through the colon via remote control and a magnetic field, ...
... from the UCLA Center for Health Policy Research, the majority ... health insurance coverage initiatives in California in 2014 are also ... health services: men, singles and those of working age. ... the federal Patient Protection and Affordable Care Act (ACA), up ...
... adhere to medications for their chronic health problems than ... risk of poor health, according to a new RAND ... a wide array of chronic illnesses such as diabetes ... being non-adherent with their medications compared to patients who ...
Cached Medicine News:Health News:Lessons from major heart trial need implementation 2Health News:Lessons from major heart trial need implementation 3Health News:Lessons from major heart trial need implementation 4Health News:Shortage of Anesthetics Reported 2Health News:Chronic Tylenol Use May Be Linked to Blood Cancer, Study Suggests 2Health News:Chronic Tylenol Use May Be Linked to Blood Cancer, Study Suggests 3Health News:A Capsule Camera Instead of a Colonoscopy? 2Health News:A Capsule Camera Instead of a Colonoscopy? 3Health News:2 new studies describe likely beneficiaries of health care reform in California 2Health News:2 new studies describe likely beneficiaries of health care reform in California 3Health News:Depression associated with poor medication adherence in patients with chronic illnesses 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: